Epistra Accelerate: AI Powers Optimization in Life Sciences
Analysis
Epistra is showcasing its AI optimization technology, Epistra Accelerate, at JID 2026, revolutionizing cell culture and media composition optimization. This innovative AI has already achieved significant results, including a 50x increase in NK cell yield and improved user experiences in precision equipment. This technology promises substantial improvements in the life sciences sector.
Key Takeaways
- •Epistra Accelerate automates optimization in cell culture and media composition using AI.
- •The AI has a proven track record, with over 60 implementations in various sectors.
- •Results include significant yield improvements in cell production and enhanced user experiences.
Reference / Citation
View Original"エピストラの条件最適化AI「Epistra Accelerate」は、60件以上の導入・検証実績を有し、大手製薬企業・装置メーカー・素材メーカーなど幅広い分野で採用されています。"
A
ASCIIFeb 9, 2026 02:30
* Cited for critical analysis under Article 32.